1. Home
  2. ATNM vs SELX Comparison

ATNM vs SELX Comparison

Compare ATNM & SELX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATNM
  • SELX
  • Stock Information
  • Founded
  • ATNM 2000
  • SELX 2021
  • Country
  • ATNM United States
  • SELX Taiwan
  • Employees
  • ATNM N/A
  • SELX N/A
  • Industry
  • ATNM Biotechnology: Pharmaceutical Preparations
  • SELX
  • Sector
  • ATNM Health Care
  • SELX
  • Exchange
  • ATNM Nasdaq
  • SELX Nasdaq
  • Market Cap
  • ATNM 51.5M
  • SELX 61.7M
  • IPO Year
  • ATNM N/A
  • SELX N/A
  • Fundamental
  • Price
  • ATNM $1.52
  • SELX $1.35
  • Analyst Decision
  • ATNM Strong Buy
  • SELX
  • Analyst Count
  • ATNM 3
  • SELX 0
  • Target Price
  • ATNM $4.67
  • SELX N/A
  • AVG Volume (30 Days)
  • ATNM 246.6K
  • SELX 3.5K
  • Earning Date
  • ATNM 08-04-2025
  • SELX 01-01-0001
  • Dividend Yield
  • ATNM N/A
  • SELX N/A
  • EPS Growth
  • ATNM N/A
  • SELX N/A
  • EPS
  • ATNM N/A
  • SELX N/A
  • Revenue
  • ATNM N/A
  • SELX $1,040,571.00
  • Revenue This Year
  • ATNM N/A
  • SELX N/A
  • Revenue Next Year
  • ATNM N/A
  • SELX N/A
  • P/E Ratio
  • ATNM N/A
  • SELX N/A
  • Revenue Growth
  • ATNM N/A
  • SELX N/A
  • 52 Week Low
  • ATNM $1.03
  • SELX $1.00
  • 52 Week High
  • ATNM $8.64
  • SELX $2.07
  • Technical
  • Relative Strength Index (RSI)
  • ATNM 42.39
  • SELX 38.61
  • Support Level
  • ATNM $1.41
  • SELX $1.22
  • Resistance Level
  • ATNM $1.95
  • SELX $1.47
  • Average True Range (ATR)
  • ATNM 0.13
  • SELX 0.09
  • MACD
  • ATNM -0.04
  • SELX -0.01
  • Stochastic Oscillator
  • ATNM 6.54
  • SELX 11.32

About ATNM Actinium Pharmaceuticals Inc. (Delaware)

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.

About SELX Semilux International Ltd. Ordinary Shares

Semilux International Ltd is a company that operates through its subsidiaries which is an optical and 3D sensing technology company that is involved in the customization, design and supply of optical components and integrated chip for various industries including autonomous driving, intelligent lighting, as well as unmanned aerial vehicles. In collaboration with its clients, TCO conceptualizes and produces high precision optics and sensing modules that are specifically customized to clients' needs for ease of integration in overall design and production. Applications for TCO's products include automotive laser headlight systems, adaptive driving beams (ADB) as well as light detection and autonomous driving systems (LiDAR).

Share on Social Networks: